Table 1.
Participants’ Baseline Characteristics (n = 1714)
| Variables | Mean ± SD | |
|---|---|---|
| Age (yr) | 51.5 ± 12.7 | |
| Body mass index (kg/m2)a | 23.8 ± 5.5 | |
| Cholesterol (mg/dL)a | 193.7 ± 43.1 | |
| Triglyceride (mg/dL)a | 120.7 ± 85.3 | |
| Fasting glucose (mg/dL)a | 98.5 ± 32.3 | |
|
| ||
| Variables | n (%) | |
|
| ||
| Gender | Male | 797 (46.5) |
| Female | 917 (53.5) | |
| Age (yr) | < 40 | 336 (19.6) |
| 40–59 | 928 (54.1) | |
| ≥60 | 450 (26.3) | |
| H. pylori IgG | − | 840 (49.0) |
| + | 874 (51.0) | |
| History of H. pylori eradication therapya | − | 1355 (83.5) |
| + | 267 (16.5) | |
| Functional dyspepsia | − | 1538 (89.7) |
| + | 176 (10.3) | |
| Atrophic gastritis | − | 1087 (63.4) |
| + | 627 (36.6) | |
| Intestinal metaplasia | − | 1461 (85.2) |
| + | 253 (14.8) | |
| Relatives with gastric cancera | − | 1488 (86.9) |
| + | 224 (13.1) | |
| Smokinga | − | 1146 (67.0) |
| + | 565 (33.0) | |
| Alcohola | − | 763 (44.6) |
| + | 947 (55.4) | |
| Residencea | Rural | 284 (16.7) |
| Urban | 1415 (83.3) | |
| Educationa | Below college | 790 (46.6) |
| Above college | 905 (53.4) | |
| Income level ($/mo)a | < 3000 | 470 (30.3) |
| 3000–9000 | 865 (55.7) | |
| ≥9000 | 218 (12.7) | |
| NSAIDs use above 1/wka | − | 1546 (90.4) |
| + | 164 (9.6) | |
| Consumption of dairy productsa | − | 1338 (78.3) |
| + | 371 (21.7) | |
| High salt dieta | − | 1500 (87.9) |
| + | 207 (12.1) | |
a
Some data are missing. Missing values are not included.
SD, standard deviation; H. pylori, Helicobacter pylori; IgG, immunoglobulin G; NSAIDs, non-steroidal anti-inflammatory drugs.